wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q37336482-A715AAB1-89D4-4A86-A406-66D6866809E9
Q37336482-A715AAB1-89D4-4A86-A406-66D6866809E9
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37336482-A715AAB1-89D4-4A86-A406-66D6866809E9
Improving conventional or low dose metronomic chemotherapy with targeted antiangiogenic drugs.
P2860
Q37336482-A715AAB1-89D4-4A86-A406-66D6866809E9
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37336482-A715AAB1-89D4-4A86-A406-66D6866809E9
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
625743d1b8f5351417eb8e6138174fa20420c389
P2860
Phase II clinical trial results involving treatment with low-dose daily oral cyclophosphamide, weekly vinblastine, and rofecoxib in patients with advanced solid tumors.